Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? With a growing number of people living with dementia (PLWD), the practice of taking multiple medications to manage symptoms or comorbidities, i.e., polypharmacy, among PLWD has become a global health challenge. WHAT IS ADDED BY THIS REPORT? In 2015–2019, polyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shanquan, Chen, Xi, Zhang, Huanyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709303/
https://www.ncbi.nlm.nih.gov/pubmed/36483007
http://dx.doi.org/10.46234/ccdcw2022.204
_version_ 1784841121274265600
author Chen, Shanquan
Chen, Xi
Zhang, Huanyu
author_facet Chen, Shanquan
Chen, Xi
Zhang, Huanyu
author_sort Chen, Shanquan
collection PubMed
description WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? With a growing number of people living with dementia (PLWD), the practice of taking multiple medications to manage symptoms or comorbidities, i.e., polypharmacy, among PLWD has become a global health challenge. WHAT IS ADDED BY THIS REPORT? In 2015–2019, polypharmacy for PLWD varied substantially among 25 studied countries, with approximately 1 in 5 Estonian PLWD and 4 in 5 Cypriot PLWD having polypharmacy. In addition, Switzerland, Poland, Austria, and the Czech Republic have experienced a significantly increasing trend in polypharmacy for PLWD. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Countries should pay special attention to polypharmacy and make efforts to control polypharmacy among PLWD, especially in countries where the trend of polypharmacy among PLWD has been increasing.
format Online
Article
Text
id pubmed-9709303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-97093032022-12-07 Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019 Chen, Shanquan Chen, Xi Zhang, Huanyu China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? With a growing number of people living with dementia (PLWD), the practice of taking multiple medications to manage symptoms or comorbidities, i.e., polypharmacy, among PLWD has become a global health challenge. WHAT IS ADDED BY THIS REPORT? In 2015–2019, polypharmacy for PLWD varied substantially among 25 studied countries, with approximately 1 in 5 Estonian PLWD and 4 in 5 Cypriot PLWD having polypharmacy. In addition, Switzerland, Poland, Austria, and the Czech Republic have experienced a significantly increasing trend in polypharmacy for PLWD. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Countries should pay special attention to polypharmacy and make efforts to control polypharmacy among PLWD, especially in countries where the trend of polypharmacy among PLWD has been increasing. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-11-11 /pmc/articles/PMC9709303/ /pubmed/36483007 http://dx.doi.org/10.46234/ccdcw2022.204 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Chen, Shanquan
Chen, Xi
Zhang, Huanyu
Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
title Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
title_full Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
title_fullStr Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
title_full_unstemmed Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
title_short Polypharmacy Among People Living with Dementia — Israel and 24 Countries in European Union, 2015–2019
title_sort polypharmacy among people living with dementia — israel and 24 countries in european union, 2015–2019
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709303/
https://www.ncbi.nlm.nih.gov/pubmed/36483007
http://dx.doi.org/10.46234/ccdcw2022.204
work_keys_str_mv AT chenshanquan polypharmacyamongpeoplelivingwithdementiaisraeland24countriesineuropeanunion20152019
AT chenxi polypharmacyamongpeoplelivingwithdementiaisraeland24countriesineuropeanunion20152019
AT zhanghuanyu polypharmacyamongpeoplelivingwithdementiaisraeland24countriesineuropeanunion20152019

Ejemplares similares